Genotropin 12MG/36IU (Somatropina) pen pre-filed Pfizer GoQuick

What is Genotropin 12MG/36IU?

Genotropin 12MG/36IU is a prescription human growth hormone medicine containing somatropin, a recombinant form of naturally occurring human growth hormone. It is manufactured for subcutaneous administration and is used when a qualified healthcare professional has diagnosed a condition that may require growth hormone replacement or treatment.

The 12 mg presentation contains the equivalent of approximately 36 IU of somatropin. Genotropin should be purchased and used as a prescription medicine rather than treated as a general bodybuilding, muscle-building, or performance-enhancing supplement. Treatment requirements vary considerably between patients, so medical supervision is essential.

Product Information

Product name: Genotropin 12MG/36IU
Active ingredient: Somatropin
Strength: 12 mg / approximately 36 IU
Medicine type: Recombinant human growth hormone
Administration: Subcutaneous injection
Prescription status: Prescription medicine
Intended use: Growth hormone therapy under medical supervision

Uses of Genotropin 12MG/36IU

Genotropin 12MG/36IU may be prescribed for certain children and adults with clinically confirmed disorders involving insufficient growth hormone or impaired growth.

Depending on the patient and applicable prescribing guidelines, Genotropin may be used for growth hormone deficiency in children, where the body does not produce sufficient natural growth hormone for normal development.

It may also be prescribed in selected pediatric patients with growth failure associated with conditions such as Turner syndrome, Prader-Willi syndrome, or children born small for gestational age (SGA) who have not achieved adequate catch-up growth.

Another recognized use is treatment of certain children with idiopathic short stature, provided the individual meets the clinical requirements established by the prescribing physician.

In adults, somatropin therapy may be considered for confirmed adult growth hormone deficiency, including deficiency that began during childhood or developed later as a result of pituitary or hypothalamic disease, surgery, radiation treatment, or another medically established cause.

Genotropin is not appropriate for every person with short stature, low energy, reduced muscle mass, or age-related physical changes. A medical assessment is required before treatment begins.

Genotropin 12MG/36IU Dosage

The correct Genotropin dosage is individualized according to the patient’s diagnosis, age, body weight or body surface area, response to treatment, laboratory results, and potential side effects.

For pediatric growth hormone deficiency, treatment is commonly calculated according to body weight and divided into regular subcutaneous injections throughout the week. Patients with Turner syndrome, Prader-Willi syndrome, SGA-related growth failure, or idiopathic short stature may require different weight-based treatment ranges.

For adults with growth hormone deficiency, treatment is generally started at a lower daily dose and adjusted gradually according to clinical response and measurements such as serum IGF-1 levels.

The exact dose should always come from the prescribing healthcare professional. Patients should not increase, decrease, combine, or discontinue Genotropin without medical advice.

Possible Side Effects of Genotropin

Like other somatropin medicines, Genotropin 12MG/36IU may cause side effects. The type and severity of reactions vary between individuals.

Commonly reported effects can include:

• Joint pain or stiffness
• Muscle discomfort
• Swelling of the hands or feet
• Headache
• Injection-site reactions
• Tingling or numbness
• Fluid retention
• Upper respiratory symptoms

Somatropin may also affect blood glucose levels and can require closer monitoring in people with diabetes or an increased risk of glucose intolerance.

More serious reactions are possible. Patients should obtain medical advice promptly if they develop severe headache, visual disturbance, persistent vomiting, significant swelling, breathing difficulty, unusual abdominal pain, or another severe or unexpected reaction.

Important Precautions

Before using Genotropin 12MG/36IU, the prescribing healthcare professional should be informed about existing medical conditions, previous cancer treatment, diabetes, thyroid disorders, respiratory problems, pregnancy, and other medicines or hormone therapies being taken.

Genotropin should not be combined with testosterone, insulin, thyroid hormones, anabolic steroids, or other hormone products unless the combination has been specifically prescribed and monitored by a qualified clinician.

Children receiving long-term treatment normally require regular monitoring of growth, development, thyroid function, glucose metabolism, and treatment response. Adults may also require ongoing clinical and laboratory assessment.

Storage and Handling

Genotropin should be stored according to the temperature and handling requirements printed on the original product packaging and patient information leaflet. Correct refrigeration may be required depending on the presentation and whether the medicine has been prepared for use.

Keep the medicine protected from excessive heat and improper storage conditions. Always inspect the packaging, expiry date, cartridge or device, and product condition before administration.

Genotropin 12MG/36IU is a prescription somatropin product intended for medically supervised growth hormone therapy. Use only the dose and treatment schedule prescribed specifically for the individual patient.